跳至主要内容
临床试验/ISRCTN35253449
ISRCTN35253449已完成不适用

Prevention of Catheter Lumen Occlusion with recombinant tissue plasminogen activator (rT-PA) versus Heparin (Pre-CLOT): A Double Blind Randomized Trial

niversity of Calgary (Canada)0 个研究点目标入组 340 人开始时间: 2005年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. End-stage renal disease (ESRD) patients 18 years of age and older with newly inserted permanent, tunnelled, dual-lumen catheters
  • 2. Naive to study but not naive to catheters
  • 3. Expected to use catheter for at least six months
  • 4. Frequency of dialysis three times per week
  • 5. Baseline international normalised ratio (INR) less than or equal to 1.3
  • 6. Baseline platelet count greater than or equal to 60

排除标准

  • 1. Use of systemic anticoagulation
  • 2. Insertion of catheter by guide-wire exchange
  • 3. Insertion of catheter into femoral vein
  • 4. Current use of antibiotics for catheter-related bacteraemia
  • 5. Major haemorrhage within prior 4 weeks
  • 6. History of intra-cranial or intra-spinal neoplasm
  • 7. Allergy to rT-PA
  • 8. Active pericarditis
  • 9. Weight less than 30 kg
  • 10. Pregnant or lactating
  • 11. Major surgery in past 48 hours
  • 12. Presence of fever

研究者

发起方
niversity of Calgary (Canada)

相似试验

Prevention of Catheter Lumen Occlusion with... | 临床试验